intt20230803_8k.htm
false 0001036262 0001036262 2023-08-04 2023-08-04
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
August 4, 2023
Date of Report (Date of earliest event reported)
 
inTEST Corporation
(Exact Name of Registrant as Specified in its Charter)
 
Delaware
(State or Other Jurisdiction of Incorporation)
1-36117
(Commission File Number)
22-2370659
(I.R.S. Employer Identification No.)
 
804 East Gate Drive, Suite 200, Mt. Laurel, New Jersey 08054
(Address of Principal Executive Offices, including zip code)
 
(856) 505-8800
(Registrant's Telephone Number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written Communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
Trading Symbol
Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share
INTT
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
 
Emerging growth company     
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 2.02.    Results of Operations and Financial Condition
 
On August 4, 2023, inTEST Corporation (the "Company") issued a press release regarding its financial results for the second quarter ended June 30, 2023.
 
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01.    Financial Statements and Exhibits
 
(d) Exhibits
 
Exhibit No.
Description
99.1
104
Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
inTEST CORPORATION
   
   
   
   
 
By:   /s/ Duncan Gilmour
 
Duncan Gilmour
 
Chief Financial Officer, Treasurer and Secretary
 
Date:   August 4, 2023
 
 
ex_554610.htm

Exhibit 99.1

 

https://cdn.kscope.io/ede7c9bec4bd19c5c5a1ed0b71f71f94-image01.jpg
https://cdn.kscope.io/ede7c9bec4bd19c5c5a1ed0b71f71f94-image02.jpg
   

 

804 East Gate Drive, Suite 200 ● Mount Laurel, NJ 08054

 

for immediate release          

 

inTEST Reports Record Revenue of $32.6 Million
for the 2023 Second Quarter with Net Earnings Growth of 32% Year-over-Year

 

 

Continued execution of 5-Point Strategy generated 10% revenue growth year-over-year achieving upper end of guidance range

 

 

Demonstrated strong operating leverage with 22.6% operating income growth year-over-year to $3.3 million

 

 

Delivered net earnings of $2.8 million, up 32.0% for a net margin of 8.6%, and earnings per diluted share of $0.24, up 20% over prior-year period

 

 

Adjusted EBITDA (Non-GAAP)(1) was $4.8 million and adjusted EBITDA margin (Non-GAAP)(1) was 14.7%

 

 

Completed $20 Million At-The-Market Offering at an Average Sales Price of $21.70 per Share

 

 

Updating full year revenue guidance to $127 million to $131 million

 

MT. LAUREL, NJ – August 4, 2023 - inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include automotive/EV, defense/aerospace, industrial, life sciences, security, and semiconductor (“semi”), today announced financial results for the quarter ended June 30, 2023.

 

Nick Grant, President and CEO, commented, “The inTEST team continues to deliver to plan and we believe our efforts to diversify our markets have served us well. Sales grew year-over-year in the semiconductor markets, particularly in the backend with continued demand for our high quality, custom manipulators, integrated docking and electrical interface solutions for mixed-signal and analog integrated circuit production testing. There was also strong demand for our thermal test solutions for the defense/aerospace markets, our industrial grade image capture technology for the security industry, and a breadth of our solutions for other markets. Encouragingly, orders were up 2% sequentially driven by demand from our industrial, defense/aerospace, automotive/EV, security and other markets. This included new orders for our Thermonics chillers for testing, development and production of high-powered traction inverters used in EVs, as well as the growing recognition of our induction heating solutions as an environmentally preferred technology in many industrial applications.”

 

He continued, “We are actively executing on our initiatives to expand our market presence, develop new products, and identify opportunities for increased aftermarket support. We are building the talent pool and culture to achieve our goals while also continuing to pursue acquisition targets to enhance our product offerings, expand our addressable markets and deepen our presence in our served industries.”

 


(1) Adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures.  Further information can be found under Non-GAAP Financial Measures.”  See also the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.

 

 

-MORE-

 

 

 

Second Quarter 2023 Review (see revenue by market and by segments in accompanying tables)

 

   

Three Months Ended

 

($ in 000s)

                 

Change

           

Change

 
   

6/30/2023

   

6/30/2022

    $    

%

   

3/31/2023

    $    

%

 

Revenue

  $ 32,558     $ 29,571     $ 2,987       10.1 %   $ 31,919     $ 639       2.0 %

Gross profit

  $ 15,030     $ 13,548     $ 1,482       10.9 %   $ 15,052     $ (22 )     -0.1 %

Gross margin

    46.2 %     45.8 %                     47.2 %                

Operating expenses (incl. intangible amort.)

  $ 11,686     $ 10,820     $ 866       8.0 %   $ 11,534     $ 152       1.3 %

Operating income

  $ 3,344     $ 2,728     $ 616       22.6 %   $ 3,518     $ (174 )     -4.9 %

Operating margin

    10.3 %     9.2 %                     11.0 %                

Net earnings

  $ 2,793     $ 2,116     $ 677       32.0 %   $ 2,817     $ (24 )     -0.9 %

Net margin

    8.6 %     7.2 %                     8.8 %                

Earnings per diluted share (“EPS”)

  $ 0.24     $ 0.20     $ 0.04       20.0 %   $ 0.25     $ (0.01 )     -4.0 %

Adjusted net earnings (Non-GAAP) (2)

  $ 3,227     $ 2,719     $ 508       18.7 %   $ 3,269     $ (42 )     -1.3 %

Adjusted EPS (Non-GAAP) (2)

  $ 0.28     $ 0.25     $ 0.03       12.0 %   $ 0.29     $ (0.01 )     -3.4 %

Adjusted EBITDA (Non-GAAP) (2)

  $ 4,795     $ 4,193     $ 602       14.4 %   $ 4,826     $ (31 )     -0.6 %

Adjusted EBITDA margin (Non-GAAP) (2)

    14.7 %     14.2 %                     15.1 %                

(2) Adjusted net earnings, adjusted EPS, adjusted EBITDA, and adjusted EBITDA margin are non-GAAP financial measures. Further information can be found under Non-GAAP Financial Measures. See also the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.

 

Compared with the prior-year period, revenue increased $3.0 million, or 10%. Revenue related to the defense/aerospace industry more than doubled to $3.9 million from higher sales of thermal test chambers and flying probe test sets. Semiconductor industry revenue of $18.8 million was up 15% from strong sales for both front-end applications of induction heating solutions for silicon carbide and epitaxy crystal growth and traditional back-end semi testing applications.

 

Compared with the first quarter of 2023, growth in semi market revenue was primarily driven by higher front-end related sales, which increased 27%. Defense/aerospace revenue was up 37% driven by greater sales of thermal test chambers. Sales to industrial, automotive/EV, life sciences and security experienced modest declines sequentially primarily reflecting the variability in timing of customer needs from quarter to quarter.

 

Gross margin expanded 40 basis points compared with the prior-year period. On a sequential basis, it contracted
100 basis points and was in line with guidance. Gross margin in the first quarter of 2023 benefitted from favorable product mix.

 

Operating expenses were up $0.9 million over the prior-year period, reflecting annual merit increases and continued investments in engineering, sales and marketing. Nonetheless, second quarter operating expenses as a percent of revenue improved to 35.9% compared with 36.6% in last year’s second quarter, which we believe demonstrates continued operating leverage improvement as sales grow. This operating leverage improvement contributed to the 22.6% growth in operating income compared with last year’s second quarter.

 

Balance Sheet and Cash Flow Review

 

Cash and cash equivalents at the end of the reported period were $37.4 million. This was an increase of $22.0 million over the trailing first quarter of 2023, reflecting $2.9 million in cash generated by operations combined with
$19.2 million in net proceeds from the recently completed At-The-Market (“ATM”) equity offering. At quarter end, total debt was $14.1 million, down $1.0 million from March 31, 2023. For the first half of 2023, the Company generated $5.3 million in cash from operations assisted by improving working capital efficiencies as supply chains normalized, enabling inventory improvements.

 

Capital expenditures were $375,000 in the 2023 second quarter, similar to last year’s second quarter. For the first six months, capital expenditures were $709,000, also in line with last year.

 

 

-MORE-

 

 

 

 

Second Quarter 2023 Orders and Backlog (see orders by market in accompanying tables)

 

   

Three Months Ended

 
                   

Change

           

Change

 
   

6/30/2023

   

6/30/2022

    $    

%

   

3/31/2023

    $    

%

 

Orders

  $ 31,431     $ 40,518     $ (9,087 )     -22.4 %   $ 30,824     $ 607       2.0 %

Backlog (at quarter end)

  $ 44,578     $ 45,981     $ (1,403 )     -3.1 %   $ 45,705     $ (1,127 )     -2.5 %

 

Orders received in the second quarter were 22% lower compared with the record level achieved in the prior-year period. Increased demand from the industrial, defense/aerospace and automotive/EV markets helped to offset lower demand from the semi, life sciences, security and other markets. Orders more than doubled for the industrial markets, grew 70% in defense/aerospace, and increased 19% in automotive/EV. Sequentially, orders grew across most markets with notable strength in security, defense/aerospace, automotive/EV, industrial and other markets.

 

Backlog at June 30, 2023, was $44.6 million, down 3.1% and 2.5% from June 30, 2022 and March 31, 2023, respectively. Approximately 45% of backlog is expected to ship beyond the third quarter of 2023.

 

Third Quarter and Full Year 2023 Outlook

 

Revenue for the third quarter of 2023 is expected to be similar to the second quarter with gross margin of approximately 46%. Third quarter 2023 operating expenses, including amortization, are also expected to be similar to the second quarter. Intangible asset amortization is expected to be approximately $520,000 pre-tax, which is approximately $430,000 after tax, or $0.03 per share. Interest expense is expected to be approximately $175,000 for the quarter and the effective tax rate is expected to be approximately 16% to 17% for the year. The Company should benefit from interest income due to its higher cash balance which should mostly offset the increase in weighted average shares from the recently completed ATM. Weighted average shares are expected to be about 12.4 million in the third quarter.

 

Third quarter 2023 estimated EPS is expected to be in the range of $0.20 to $0.24, while third quarter estimated adjusted EPS (Non-GAAP)(3) is expected to be in the range of $0.23 to $0.27.

 

For the full year of 2023, based on strong second quarter results, the Company is updating its guidance as follows:

 

(as of August 4, 2023)

 

Current 2023 Guidance

 

Previous Guidance

 

Revenue

 

$127 million to $131 million

 

$125 million to $130 million

 

Gross margin

 

~46%

 

~46% to ~47%

 

Operating expenses

 

$46 million to $47 million

 

$45 million to $47 million

 

Intangible asset amort expense

 

Unchanged

 

~$2.1 million

 

Intangible asset amort exp. after tax

 

Unchanged

 

~$1.7 million

 

Effective tax rate

 

Unchanged

  16% to 17%  

Capital expenditures

 

Unchanged

 

1% to 2% of sales

 

Weighted average share count

 

~12.4 million in Q3 2023

 

NA

 

 

The foregoing guidance is based on management’s current views with respect to operating and market conditions and customers’ forecasts. It also assumes macroeconomic conditions remain unchanged through the end of the year and does not take into account any extraordinary non-operating expenses that may occur from time to time. Actual results may differ materially from what is provided here today as a result of, among other things, the factors described under “Forward-Looking Statements” below. Further information about non-GAAP measures can be found under “Non-GAAP Financial Measures” and the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.

 


 

(3) Third quarter 2023 estimated adjusted EPS is a forward-looking non-GAAP financial measure. Further information can be found under Forward-looking Non-GAAP Financial Measures. See also the reconciliations of GAAP financial measures to non-GAAP financial measures that accompany this press release.

 

 

-MORE-

 

 

 

 

Conference Call and Webcast
The Company will host a conference call and webcast today at 8:30 a.m. ET. During the conference call, management will review the financial and operating results and discuss inTEST’s corporate strategy and outlook. A question-and-answer session will follow. To listen to the live call, dial (201) 689-8263. In addition, the webcast and slide presentation may be found at https://www.intest.com/investor-relations.

 

A telephonic replay will be available from 11:30 a.m. ET on the day of the call through Friday, August 11, 2023. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13739637. The webcast replay can be accessed via the investor relations section at www.intest.com, where a transcript will also be posted once available.

 

About inTEST Corporation
inTEST Corporation is a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets including automotive/EV, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry. Backed by decades of engineering expertise and a culture of operational excellence, inTEST solves difficult thermal, mechanical, and electronic challenges for customers worldwide while generating strong cash flow and profits. inTEST’s strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach, and market expansion. For more information, visit www.intest.com.

 

Non-GAAP Financial Measures and Forward-Looking Non-GAAP Financial Measures
In addition to disclosing results that are determined in accordance with generally accepted accounting practices in the United States (“GAAP”), we also disclose non-GAAP financial measures. These non-GAAP financial measures consist of adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin.

 

Definition of Non-GAAP Measures
The Company defines these non-GAAP measures as follows:

 

Adjusted net earnings is derived by adding acquired intangible amortization, adjusted for the related income tax expense (benefit), to net earnings.

 

Adjusted earnings per diluted share (adjusted EPS) is derived by dividing adjusted net earnings by diluted weighted average shares outstanding.

 

Adjusted EBITDA is derived by adding acquired intangible amortization, net interest expense, income tax expense, depreciation, and stock-based compensation expense to net earnings.

 

Adjusted EBITDA margin is derived by dividing adjusted EBITDA by revenue.

 

These results are provided as a complement to the results provided in accordance with GAAP. Adjusted net earnings and adjusted earnings per diluted share (adjusted EPS) are non-GAAP financial measures presented to provide investors with meaningful, supplemental information regarding our baseline performance before acquired intangible amortization charges as management believes this expense may not be indicative of our underlying operating performance. Adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures presented primarily as a measure of liquidity as they exclude non-cash charges for acquired intangible amortization, depreciation and stock-based compensation. In addition, adjusted EBITDA and adjusted EBITDA margin also exclude the impact of interest income or expense and income tax expense or benefit, as management believes these expenses may not be indicative of our underlying operating performance.

 

Managements Use of Non-GAAP Measures
The non-GAAP financial measures presented in this press release are used by management to make operational decisions, to forecast future operational results, and for comparison with our business plan, historical operating results and the operating results of our peers. Reconciliations from net earnings and earnings per diluted share (EPS) to adjusted net earnings and adjusted earnings per diluted share (adjusted EPS) and from net earnings and net margin to adjusted EBITDA and adjusted EBITDA margin, are contained in the tables below.

 

 

-MORE-

 

 

 

 

Limitations of adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin
Each of our non-GAAP measures have limitations as analytical tools. They should not be viewed in isolation or as a substitute for GAAP measures of earnings or cash flows. Limitations may include the cash portion of interest expense, income tax (benefit) provision, charges related to intangible asset amortization and stock-based compensation expense. These items could significantly affect our financial results.

 

Management believes these Non-GAAP financial measures are important in evaluating our performance, results of operations, and financial position. We use non-GAAP financial measures to supplement our GAAP results in order to provide a more complete understanding of the factors and trends affecting our business.

 

Adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin are not alternatives to net earnings, earnings per diluted share or margin as calculated and presented in accordance with GAAP. As such, they should not be considered or relied upon as substitutes or alternatives for any such GAAP financial measure. We strongly urge you to review the reconciliations of adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin along with our financial statements included elsewhere in this press release. We also strongly urge you not to rely on any single financial measure to evaluate our business. In addition, because adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin are not measures of financial performance under GAAP and are susceptible to varying calculations, the adjusted net earnings, adjusted earnings per diluted share (adjusted EPS), adjusted EBITDA, and adjusted EBITDA margin measures as presented in this press release may differ from and may not be comparable to similarly titled measures used by other companies.

 

Forward-Looking Non-GAAP Financial Measures
This release includes certain forward-looking non-GAAP financial measures, including estimated adjusted earnings per diluted share (estimated adjusted EPS). We have provided these non-GAAP measures for future guidance for the same reasons that were outlined above for historical non-GAAP measures.

 

We have reconciled non-GAAP forward-looking estimated adjusted EPS to its most directly comparable GAAP measure. The reconciliation from estimated net earnings per diluted share (EPS) to estimated adjusted EPS is contained in the table below.

 

Key Performance Indicators
In addition to the foregoing non-GAAP measures, management uses the following key performance metrics to analyze and measure the Company’s financial performance and results of operations: orders and backlog. Management uses orders and backlog as measures of current and future business and financial performance, and these may not be comparable with measures provided by other companies. Orders represent written communications received from customers requesting the Company to provide products and/or services. Backlog is calculated on the basis of firm purchase orders we receive for which revenue has not yet been recognized. Management believes tracking orders and backlog are useful as it often times is a leading indicator of future performance. In accordance with industry practice, contracts may include provisions for cancellation, termination, or suspension at the discretion of the customer.

 

Given that each of orders and backlog are operational measures and that the Company's methodology for calculating orders and backlog does not meet the definition of a non-GAAP measure, as that term is defined by the U.S. Securities and Exchange Commission, a quantitative reconciliation for each is not required or provided.

 

 

-MORE-

 

 

 

Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements do not convey historical information but relate to predicted or potential future events and financial results, such as statements of the Company’s plans, strategies and intentions, or our future performance or goals, that are based upon management's current expectations. These forward-looking statements can often be identified by the use of forward-looking terminology such as “continue,” “believe,” “could,” “expects,” “may,” “will,” “should,” “plan,” “potential,” “forecasts,” “outlook,” “anticipates,” “targets,” “estimates,” or similar terminology. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, but are not limited to, any mentioned in this press release as well as the Company’s ability to execute on its 5-Point Strategy, achieve high single-digit growth in 2023, realize the potential benefits of acquisitions and successfully integrate any acquired operations, grow the Company’s presence in its key target and international markets, manage supply chain challenges, convert backlog to sales and to ship product in a timely manner; the success of the Company’s strategy to diversify its markets; the impact of inflation on the Company’s business and financial condition; indications of a change in the market cycles in the semi market or other markets served; changes in business conditions and general economic conditions both domestically and globally including rising interest rates and fluctuation in foreign currency exchange rates; changes in the demand for semiconductors; access to capital and the ability to borrow funds or raise capital to finance potential acquisitions or for working capital; changes in the rates and timing of capital expenditures by the Company’s customers; and other risk factors set forth from time to time in the Company’s Securities and Exchange Commission filings, including, but not limited to, the Annual Report on Form 10-K for the year ended December 31, 2022. Any forward-looking statement made by the Company in this press release is based only on information currently available to management and speaks to circumstances only as of the date on which it is made. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events, except as required by law.

 

Contacts:

inTEST Corporation

Investors:

Duncan Gilmour

Deborah K. Pawlowski, Kei Advisors LLC

Chief Financial Officer and Treasurer

dpawlowski@keiadvisors.com

Tel: (856) 505-8999

Tel: (716) 843-3908

 

 

 

– FINANCIAL TABLES FOLLOW –

 

 

 

-MORE-

 

 

 

inTEST CORPORATION

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

 

   

Three Months Ended
June 30,

   

Six Months Ended
June 30,

 
   

2023

   

2022

   

2023

   

2022

 
                                 

Revenue

  $ 32,558     $ 29,571     $ 64,477     $ 53,652  

Cost of revenue

    17,528       16,023       34,395       29,091  

Gross profit

    15,030       13,548       30,082       24,561  
                                 

Operating expenses:

                               

Selling expense

    4,661       4,033       9,116       7,489  

Engineering and product development expense

    1,983       1,859       3,887       3,783  

General and administrative expense

    5,042       4,928       10,217       9,759  

Total operating expenses

    11,686       10,820       23,220       21,031  
                                 

Operating income

    3,344       2,728       6,862       3,530  

Interest expense

    (176

)

    (141

)

    (358

)

    (278

)

Other income (expense)

    197       (17

)

    255       (27

)

                                 

Earnings before income tax expense

    3,365       2,570       6,759       3,225  

Income tax expense

    572       454       1,149       532  
                                 

Net earnings

  $ 2,793     $ 2,116     $ 5,610     $ 2,693  
                                 

Earnings per common share - basic

  $ 0.25     $ 0.20     $ 0.51     $ 0.25  
                                 

Weighted average common shares outstanding - basic

    11,241,183       10,653,268       10,998,456       10,635,270  
                                 

Earnings per common share - diluted

  $ 0.24     $ 0.20     $ 0.49     $ 0.25  
                                 

Weighted average common shares and common share equivalents outstanding - diluted

    11,696,569       10,814,799       11,392,617       10,828,696  

 

 

-MORE-

 

 

 

 

inTEST CORPORATION

Consolidated Balance Sheets

(In thousands)

 

   

June 30,

   

December 31,

 
   

2023

   

2022

 
   

(Unaudited)

         

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 37,435     $ 13,434  

Restricted cash

    -       1,142  

Trade accounts receivable, net of allowance for credit losses of $501 and $496, respectively

    21,581       21,215  

Inventories

    23,070       22,565  

Prepaid expenses and other current assets

    1,495       1,695  

Total current assets

    83,581       60,051  

Property and equipment:

               

Machinery and equipment

    6,779       6,625  

Leasehold improvements

    3,520       3,242  

Gross property and equipment

    10,299       9,867  

Less: accumulated depreciation

    (7,081

)

    (6,735

)

Net property and equipment

    3,218       3,132  

Right-of-use assets, net

    5,177       5,770  

Goodwill

    21,707       21,605  

Intangible assets, net

    17,613       18,559  

Deferred tax assets

    965       280  

Restricted certificates of deposit

    100       100  

Other assets

    496       569  

Total assets

  $ 132,857     $ 110,066  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Current portion of Term Note

  $ 4,100     $ 4,100  

Current portion of operating lease liabilities

    1,731       1,645  

Accounts payable

    5,735       7,394  

Accrued wages and benefits

    3,570       3,907  

Accrued professional fees

    1,010       884  

Customer deposits and deferred revenue

    5,176       4,498  

Accrued sales commissions

    1,202       1,468  

Domestic and foreign income taxes payable

    1,184       1,409  

Other current liabilities

    1,660       1,564  

Total current liabilities

    25,368       26,869  

Operating lease liabilities, net of current portion

    3,959       4,705  

Term Note, net of current portion

    9,992       12,042  

Contingent consideration

    1,063       1,039  

Other liabilities

    411       455  

Total liabilities

    40,793       45,110  

Commitments and Contingencies

               

Stockholders' equity:

               

Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding

    -       -  

Common stock, $0.01 par value; 20,000,000 shares authorized; 12,185,220 and 11,063,271 shares issued, respectively

    122       111  

Additional paid-in capital

    53,296       31,987  

Retained earnings

    38,464       32,854  

Accumulated other comprehensive earnings

    470       218  

Treasury stock, at cost; 38,514 and 34,308 shares, respectively

    (288

)

    (214

)

Total stockholders' equity

    92,064       64,956  

Total liabilities and stockholders' equity

  $ 132,857     $ 110,066  

 

 

-MORE-

 

 

 

inTEST CORPORATION

Consolidated Statements of Cash Flows

(In thousands)

 

(Unaudited)

 

Six Months Ended
June 30,

 
   

2023

   

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net earnings

  $ 5,610     $ 2,693  

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:

               

Depreciation and amortization

    2,350       2,528  

Provision for excess and obsolete inventory

    266       230  

Foreign exchange (gain) loss

    (47

)

    98  

Amortization of deferred compensation related to stock-based awards

    1,079       923  

Discount on shares sold under Employee Stock Purchase Plan

    14       18  

Loss on disposal of property and equipment

    98       61  

Deferred income tax benefit

    (685

)

    (805

)

Changes in assets and liabilities:

               

Trade accounts receivable

    (372

)

    (6,607

)

Inventories

    (693

)

    (4,894

)

Prepaid expenses and other current assets

    212       (87

)

Other assets

    2       (395

)

Operating lease liabilities

    (849

)

    (701

)

Accounts payable

    (1,607

)

    3,506  

Accrued wages and benefits

    (351

)

    (981

)

Accrued professional fees

    117       (471

)

Customer deposits and deferred revenue

    625       (264

)

Accrued sales commissions

    (266

)

    219  

Domestic and foreign income taxes payable

    (220

)

    (477

)

Other current liabilities

    76       264  

Other liabilities

    (17

)

    61  

Net cash provided by (used in) operating activities

    5,342       (5,081

)

                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Refund of final working capital adjustment related to Acculogic

    -       371  

Purchase of property and equipment

    (709

)

    (708

)

Purchase of short-term investments

    -       (3,477

)

Net cash used in investing activities

    (709

)

    (3,814

)

                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Net proceeds from public offering of common stock

    19,244       -  

Repayments of Term Note

    (2,050

)

    (1,908

)

Proceeds from shares sold under Employee Stock Purchase Plan

    83       103  

Proceeds from stock options exercised

    900       -  

Acquisition of treasury stock-shares surrendered by employees to satisfy tax liability

    (74

)

    (10

)

Net cash provided by (used in) financing activities

    18,103       (1,815

)

                 

Effects of exchange rates on cash

    123       58  
                 

Net cash provided by (used in) all activities

    22,859       (10,652

)

Cash and cash equivalents at beginning of period

    14,576       21,195  

Cash and cash equivalents at end of period

  $ 37,435     $ 10,543  
                 

Cash payments for:

               

Domestic and foreign income taxes

  $ 2,060     $ 1,865  

 

 

-MORE-

 

 

 

inTEST CORPORATION

 

Revenue by Market

(In thousands)

(Unaudited)

 

($ in 000s)

 

Three Months Ended

 
                                   

Change

                   

Change

 
   

6/30/2023

   

6/30/2022

    $    

%

   

3/31/2023

    $    

%

 

Revenue

                                                                               

Semi

  $ 18,833       57.8 %   $ 16,409       55.5 %   $ 2,424       14.8 %   $ 17,683       55.4 %   $ 1,150       6.5 %

Industrial

    2,806       8.6 %     2,930       9.9 %     (124 )     -4.2 %     3,137       9.8 %     (331 )     -10.6 %

Auto/EV

    1,542       4.7 %     3,594       12.2 %     (2,052 )     -57.1 %     2,597       8.1 %     (1,055 )     -40.6 %

Life Sciences

    1,135       3.5 %     1,169       3.9 %     (34 )     -2.9 %     1,513       4.8 %     (378 )     -25.0 %

Defense/Aerospace

    3,890       11.9 %     1,423       4.8 %     2,467       173.4 %     2,839       8.9 %     1,051       37.0 %

Security

    936       2.9 %     794       2.7 %     142       17.9 %     966       3.0 %     (30 )     -3.1 %

Other

    3,416       10.6 %     3,252       11.0 %     164       5.0 %     3,184       10.0 %     232       7.3 %
    $ 32,558       100.0 %   $ 29,571       100.0 %   $ 2,987       10.1 %   $ 31,919       100.0 %   $ 639       2.0 %

 

 

Orders by Market

(In thousands)

(Unaudited)

($ in 000s)

 

Three Months Ended

 
                                   

Change

                   

Change

 
   

6/30/2023

   

6/30/2022

    $    

%

   

3/31/2023

    $    

%

 

Orders

                                                                               

Semi

  $ 14,721       46.9 %   $ 26,732       66.0 %   $ (12,011 )     -44.9 %   $ 18,346       59.5 %   $ (3,625 )     -19.8 %

Industrial

    5,756       18.3 %     2,366       5.8 %     3,390       143.3 %     4,142       13.5 %     1,614       39.0 %

Auto/EV

    3,276       10.4 %     2,750       6.8 %     526       19.1 %     2,044       6.6 %     1,232       60.3 %

Life Sciences

    609       1.9 %     1,535       3.8 %     (926 )     -60.3 %     1,936       6.3 %     (1,327 )     -68.5 %

Defense/Aerospace

    3,216       10.2 %     1,897       4.7 %     1,319       69.5 %     1,977       6.4 %     1,239       62.7 %

Security

    456       1.5 %     989       2.4 %     (533 )     -53.9 %     212       0.7 %     244       115.1 %

Other

    3,397       10.8 %     4,249       10.5 %     (852 )     -20.1 %     2,167       7.0 %     1,230       56.8 %
    $ 31,431       100.0 %   $ 40,518       100.0 %   $ (9,087 )     -22.4 %   $ 30,824       100.0 %   $ 607       2.0 %

 

 

-MORE-

 

 

 

inTEST CORPORATION

 

Segment Data

(In thousands)

(Unaudited)

 

   

Three Months Ended

June 30,

   

Six Months Ended

June 30

 
   

2023

   

2022

   

2023

   

2022

 

Revenue:

                               

Electronic Test

  $ 10,993     $ 9,797     $ 21,364     $ 18,575  

Environmental Technologies

    8,136       7,507       16,178       14,500  

Process Technologies

    13,429       12,267       26,935       20,577  

Total Revenue

  $ 32,558     $ 29,571     $ 64,477     $ 53,652  
                                 

Division operating income:

                               

Electronic Test

  $ 2,641     $ 2,193     $ 5,219     $ 4,080  

Environmental Technologies

    943       1,070       1,956       1,872  

Process Technologies

    2,592       2,569       5,268       3,299  

Total division operating income

    6,176       5,832       12,443       9,251  
                                 

Corporate expenses

    (2,309

)

    (2,339

)

    (4,514

)

    (4,174

)

Acquired intangible amortization

    (523

)

    (765

)

    (1,067

)

    (1,547

)

Interest expense

    (176

)

    (141

)

    (358

)

    (278

)

Other income (expense)

    197       (17

)

    255       (27

)

Earnings before income tax expense

  $ 3,365     $ 2,570     $ 6,759     $ 3,225  

 

 

-MORE-

 

 

 

 

inTEST CORPORATION

Reconciliation of GAAP Measures to Non-GAAP Financial Measures

(In thousands, except per share and percentage data)
(Unaudited)

 

Reconciliation of Net Earnings to Adjusted Net Earnings (Non-GAAP) and
Earnings Per Diluted Share to Adjusted EPS (Non-GAAP):

 

   

Three Months Ended

 
   

6/30/2023

   

6/30/2022

   

3/31/2023

 
                         

Net earnings

  $ 2,793     $ 2,116     $ 2,817  

Acquired intangible amortization

    523       765       544  

Tax adjustments

    (89 )     (162 )     (92 )

Adjusted net earnings (Non-GAAP)

  $ 3,227     $ 2,719     $ 3,269  
                         

Diluted weighted average shares outstanding

    11,697       10,815       11,089  

Earnings per diluted share:

                       

Net earnings

  $ 0.24     $ 0.20     $ 0.25  

Acquired intangible amortization

    0.05       0.07       0.05  

Tax adjustments

    (0.01 )     (0.02 )     (0.01 )

Adjusted EPS (Non-GAAP)

  $ 0.28     $ 0.25     $ 0.29  

 

Reconciliation of Net Earnings and Net Margin to Adjusted EBITDA (Non-GAAP) and
Adjusted EBITDA Margin (Non-GAAP):

 

   

Three Months Ended

 
   

6/30/2023

   

6/30/2022

   

3/31/2023

 
                         

Net earnings

  $ 2,793     $ 2,116     $ 2,817  

Acquired intangible amortization

    523       765       544  

Net interest expense

    43       133       169  

Income tax expense

    572       454       577  

Depreciation

    259       174       245  

Non-cash stock-based compensation

    605       551       474  

Adjusted EBITDA (Non-GAAP)

  $ 4,795     $ 4,193     $ 4,826  

Revenue

    32,558       29,571       31,919  

Net margin

    8.6 %     7.2 %     8.8 %

Adjusted EBITDA margin (Non-GAAP)

    14.7 %     14.2 %     15.1 %

 

Reconciliation of Third Quarter 2023 Estimated Earnings Per Diluted Share to
Estimated Adjusted EPS (Non-GAAP):

 

   

Low

   

High

 
                 

Estimated earnings per diluted share

  $ 0.20     $ 0.24  

Estimated acquired intangible amortization

    0.04       0.04  

Estimated tax adjustments

    (0.01 )     (0.01 )

Estimated adjusted EPS (Non-GAAP)

  $ 0.23     $ 0.27  

 

 

###